<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03343886</url>
  </required_header>
  <id_info>
    <org_study_id>COURAGE2020</org_study_id>
    <secondary_id>FP7/2007-2013- 316795</secondary_id>
    <secondary_id>ACI2009-1010</secondary_id>
    <secondary_id>PS09/00295</secondary_id>
    <secondary_id>PS09/01845</secondary_id>
    <secondary_id>PI12/01490</secondary_id>
    <secondary_id>PI13/00059</secondary_id>
    <secondary_id>PI16/01073</secondary_id>
    <secondary_id>PI16/00812</secondary_id>
    <nct_id>NCT03343886</nct_id>
  </id_info>
  <brief_title>Trajectories of Health in Spanish Population</brief_title>
  <official_title>Longitudinal Trajectories of Health, Disability and Well-being in Spanish Ageing Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundació Sant Joan de Déu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Age with Health is a longitudinal cohort study aimed to examine trajectories of health,
      disability and wellbeing and their determinants for Spanish ageing population. Two waves have
      carried out so far. Wave 1 (2011-2012) and Wave 2 (2014-2015). Wave 3 will be conducted 2018,
      including also a new cohort of participants (Called 2018 Cohort). The study will provide
      reliable measures of population ageing and adult health in Spain - and will provide the basis
      for cross-country comparisons with longitudinal studies conducted in other countries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design:

      A prospective cohort general population study. Three study Waves

      Sample:

      Wave 1: A nationally representative sample of non-institutionalized adults aged 18 years or
      older from the Spanish population was collected (with an over-sampling of people aged 50+
      years). A multi-stage clustered design was employed; four strata based on the number of
      inhabitants of the municipalities were built for each of the 17 Spanish autonomous
      communities. Clusters were selected within the strata with a probability of inclusion
      relative to their size. Within each cluster, households were randomly selected from a list of
      all households. In case there was more than one individual from the corresponding age group
      in the household, a random method was employed to select the individual participant. A total
      of 4,753 respondents were interviewed and signed the written consent.

      Wave 2: Wave 1 sample was re-interviewed (Wave 2) in 2014-2015. The mean follow-up period was
      3.5 years (SD = 0.18). A total of 2,528 individuals were re-interviewed. The response rate in
      the second wave was 69.5%. This cohort will be re-interviewed after 3.5 years (Wave 3).

      Wave 3: Following the same sampling methods than in Wave 1 approximately 3000 participants
      from Madrid and Barcelona will be interviewed for the first time.

      Data collection:

      Face-to-face interviews by Computer-Assisted Personal Interviewing at the respondents' homes
      by trained interviewers. All interviewers receive a standardized training. Data quality
      control is also performed.

      Main objective:

      To assess trajectories of general health, disability and well-being in Spanish ageing
      population.

      Secondary objectives:

      To identify trajectories of healthy ageing (in terms of psychical health, mental health,
      functioning and well-being) in Spanish adult population as well as their determinants To
      analyse prevalence and impact of chronic health conditions, mental health problems,
      well-being and loneliness on mortality in Spanish adult population.

      To determine risk factors for incidence and persistence of mental and physical health
      problems in Spanish ageing population.

      Hypothesis:

      The trajectories of health, functioning and well-being will be encompassed by relevant
      environmental factors such as social support, loneliness and health care utilization,
      personal factors (socio-demographic characteristics, healthy lifestyles, and high cognitive
      reserve among others) and other biological and health-related factors (weight, height, waist
      circumference, executive functions, blood pressure, grip strength, vision acuity, presence of
      mental and physical health problems and quality of life).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2011</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Wave 1 Heath Status</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: Health composite total score (Salomon, 2003). Construct: Health status. Final result: A global total score. Range: 0-100. 0 means lower health status.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Wave 1 Disability</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: World Health Organization's Disability Assessment Schedule-II (WHODAS-II). (World Health Organization, 2010). Construct: Disability. Final result: A global total score. Range: 0-100. 0 means lower disability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Wave 1 Instrumental Activities of Daily living</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: Instrumental Activities of Daily Living Scale (Lawton &amp; Brody, 1969). Construct: Instrumental activities of daily living. Final result: A global total score. Range 0-8. 0 means higher problems to perform activities.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Wave 1 Activities of Daily Living</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: The Barthel Index (Van der Putten, 1999). Construct: Activities of Daily Living. Result: A global total score. Range 0-100. 0 means higher problems to perform activities.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Wave 1 Experienced Well-being</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Abbreviated Version of the Day Reconstruction Method (Miret, et al., 2012). Construct: Experienced wellbeing.
Final Result: The used scale reports two global scores:
Positive Affect total score. Range: 0-100 where 0 means lower positive affect.
Negative Affect total score. Range 0-100 where 0 means lower negative affect.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Wave 1 Quality of life</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: World Health Organization Quality of Life-Age (WHOQOL-AGE) (Caballero, et al., 2013). Construct: Quality of life. Final Result: A global total score. Range 0-100. 0 means lower quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Wave 1 Eudaimonic Well-being</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: The Flourishing Scale (Diener, et al., 2009). Construct: Eudaimonic Wellbeing. Final result: The scale used shows a total score. Range 8-56. 8 means lower eudaimonic well-being</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 Depression</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: The World Health Organization Composite International Diagnostic Interview (CIDI). Depression module (WHO-CIDI, 1990).
Construct: Presence of Depression. Final result: Two measures of depression according to Research Diagnostic Criteria.
Presence of 12 month depression. Values (yes/no).
Presence of lifetime depression. Values (yes/no).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 Suicide behavior</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: The World Health Organization Composite International Diagnostic Interview (CIDI). Suicide module (WHO-CIDI, 1990).
Construct: Presence of Suicide behavior The instrument reports six measures of suicide behavior.
Presence of 12 month suicide ideation. Values (yes/no)
Presence of 12 month suicide planning. Values (yes/no)
Presence of 12 month suicide attempts. Values (yes/no)
Presence of lifetime suicide ideation. Values (yes/no)
Presence of lifetime suicide planning. Values (yes/no)
Presence of lifetime suicide attempts. Values (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 Anxiety</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Measure: The World Health Organization Composite International Diagnostic Interview (CIDI). Anxiety disorders module (WHO-CIDI, 1990).
Construct: Presence of anxiety Disorders Final Result: The instrument included in the study reports six measures of anxiety disorders according to Research diagnostic criteria.
Presence of 12 month panic disorder. Values (yes/no)
Presence of 12 month generalized anxiety disorder. Values (yes/no)
Presence of 12 month phobic disorder. Values (yes/no)
Presence of lifetime panic disorder. Values (yes/no)
Presence of lifetime generalized anxiety disorder. Values (yes/no)
Presence of lifetime phobic disorder. Values (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of diabetes</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of diabetes Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for diabetes Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of osteoarthritis</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of osteoarthritis Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for osteoarthritis Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of any lung disease</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of any lung disease Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for any lung disease Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of stroke</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of stroke Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for stroke Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of chest angina</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of chest angina Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for chest angina Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of arthritis</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of arthritis Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for arthritis.
Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 Blood pressure</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Blood pressure Measure: Blood pressure monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of cataracts</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of cataracts Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for cataracts Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of asthma</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of asthma Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for asthma Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of kidney disease</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of any kidney disease Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for kidney disease.
Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of liver disease</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of liver disease Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for liver disease Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of cancer</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of any kind of cancer Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for any kind of cancer Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of anaemia</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of anaemia Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for anaemia.
Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of thyroid problems</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of any thyroid problems Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for any thyroid problems.
Values: (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Wave 1 presence of glaucoma</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Presence of glaucoma Measure: Self-reported information of 12-month presence of diagnosis and/or of treatment for glaucoma. Values: (Yes/No)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Alcohol use</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Alcohol use Measure: Self-reported information of how many standard drinks per day in last 7 days have been used.
Values: four categories of alcohol use:
0= Lifetime abstainers: Participants that have never used alcohol
Occasional drinkers: Participants that have ever used alcohol but not in the previous 7 days
Infrequent heavy drinker: Participants did consume alcohol 1-2 days per week, with 5 or more standard drinks per day in last 7 days for men and 4 or more standard drinks per day in last 7 days for women.
Frequent heavy drinkers: Participants did consume alcohol 3 or more days per week with 5 or more standard drinks per day in last 7 days for men and 4 or more standard drinks per day in last 7 days for women.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Tobacco use</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Tobacco use Measure: Self-reported information of how many cigarettes/pipes/tobacco products/ have been used in the last week.
Values: Four categories of tobacco use:
0=Never smokers: Participants that have never used tobacco
Non daily smokers: Participants that have ever used tobacco but not in the previous week
Daily smokers: Participants that have used tobacco last week</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Physical activity</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Level of physical activity Scale: Global Physical Activity Questionnaire version 2 (GPAQ v2) Values: Three values of physical activity can be obtained 3=High physical activity 2=Moderate physical activity
1=Low physical activity</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Social Support</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Social Support Measure: 3-Item Oslo Social Support Scale (Abiola, 2013) Result: A global total Score Range: 3-14. 3 means lower social support</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from wave 1 Loneliness</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Loneliness Measure: Three-item University of California, Los Angeles (UCLA) Loneliness Scale (Hughes et al, 2004) Result: A total loneliness score Range: 3-9. Higher scores means higher loneliness</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Size of Social network</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Size of Social Network Measure: Berkman-Syme Social Network Index Result: A Total score Range: 0-99. Higher score indicate bigger network that lower score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Weight</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Weight Result: kilograms</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Height</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Height Measure: Centimeters</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Waist circumference</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Waist circumference. Measure: Centimeters</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Handgrip</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Handgrip. Measure: Smedley Hand Dynamometer (Stoelting Company). Result: Kilogram</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Gait speed</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Gait speed. Measure: Gaid speed test. Result: Metres per second.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from Wave 1 Cognitive Reserve</measure>
    <time_frame>Three times (each 3.5 years)</time_frame>
    <description>Construct: Reserve Cognitive. Measure: Cognitive Reserve Questionnaire (CRQ, Rami, et al 211) Result: A Total score. Range 0-25 Higher scores means higher cognitive reserve</description>
  </other_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Health, Subjective</condition>
  <condition>Disability, Evaluation</condition>
  <condition>Mental Health Wellness 1</condition>
  <condition>Chronic Disease</condition>
  <condition>Mental Disorder</condition>
  <condition>Aging</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Community-living individuals in Spain aged 18 years or older
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-institutionalized Spanish residents

          -  18 years and over

        Exclusion Criteria:

          -  Institutionalized population
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Luis Ayuso Mateos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Cabello, PhD</last_name>
    <phone>+34 914972447</phone>
    <email>maria.cabello@uam.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marta Miret, PhD</last_name>
    <phone>+34 91497 2716</phone>
    <email>marta.miret@uam.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fundació Sant Joan de Déu</name>
      <address>
        <city>Sant Boi De Llobregat</city>
        <state>Barcelona</state>
        <zip>08830</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josep Maria Haro, MD, PhD</last_name>
      <phone>(+34) 93 640 6350</phone>
      <phone_ext>12544</phone_ext>
      <email>jmharo@pssjd.org</email>
    </contact>
    <contact_backup>
      <last_name>Beatriz Olaya, PhD</last_name>
      <phone>+34 93 556 96 77</phone>
      <email>beatriz.olaya@pssjd.org</email>
    </contact_backup>
    <investigator>
      <last_name>Josep Maria Haro, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cabello, PhD</last_name>
      <phone>+914972447</phone>
      <email>maria.cabello@uam.es</email>
    </contact>
    <investigator>
      <last_name>Jose Luis Ayuso Mateos, Md, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://edadconsalud.com/</url>
    <description>Age with health website info</description>
  </link>
  <results_reference>
    <citation>Miret M, Caballero FF, Olaya B, Koskinen S, Naidoo N, Tobiasz-Adamczyk B, Leonardi M, Haro JM, Chatterji S, Ayuso-Mateos JL. Association of experienced and evaluative well-being with health in nine countries with different income levels: a cross-sectional study. Global Health. 2017 Aug 23;13(1):65. doi: 10.1186/s12992-017-0290-0.</citation>
    <PMID>28835255</PMID>
  </results_reference>
  <results_reference>
    <citation>Olaya B, Moneta MV, Démenech-Abella J, Miret M, Bayes I, Ayuso-Mateos JL, Haro JM. Mobility difficulties, physical activity and all-cause mortality risk in a nationally-representative sample of older adults. J Gerontol A Biol Sci Med Sci. 2017 Jun 19. doi: 10.1093/gerona/glx121. [Epub ahead of print]</citation>
    <PMID>28633439</PMID>
  </results_reference>
  <results_reference>
    <citation>Lara E, Koyanagi A, Domènech-Abella J, Miret M, Ayuso-Mateos JL, Haro JM. The Impact of Depression on the Development of Mild Cognitive Impairment over 3 Years of Follow-Up: A Population-Based Study. Dement Geriatr Cogn Disord. 2017;43(3-4):155-169. doi: 10.1159/000455227. Epub 2017 Feb 9.</citation>
    <PMID>28178703</PMID>
  </results_reference>
  <results_reference>
    <citation>Martín-María N, Miret M, Caballero FF, Rico-Uribe LA, Steptoe A, Chatterji S, Ayuso-Mateos JL. The Impact of Subjective Well-being on Mortality: A Meta-Analysis of Longitudinal Studies in the General Population. Psychosom Med. 2017 Jun;79(5):565-575. doi: 10.1097/PSY.0000000000000444. Review.</citation>
    <PMID>28033196</PMID>
  </results_reference>
  <results_reference>
    <citation>Lara E, Koyanagi A, Caballero F, Domènech-Abella J, Miret M, Olaya B, Rico-Uribe L, Ayuso-Mateos JL, Haro JM. Cognitive reserve is associated with quality of life: A population-based study. Exp Gerontol. 2017 Jan;87(Pt A):67-73. doi: 10.1016/j.exger.2016.10.012. Epub 2016 Nov 5.</citation>
    <PMID>27825839</PMID>
  </results_reference>
  <results_reference>
    <citation>Kamenov K, Caballero FF, Miret M, Leonardi M, Sainio P, Tobiasz-Adamczyk B, Haro JM, Chatterji S, Ayuso-Mateos JL, Cabello M. Which Are the Most Burdensome Functioning Areas in Depression? A Cross-National Study. Front Psychol. 2016 Aug 31;7:1342. doi: 10.3389/fpsyg.2016.01342. eCollection 2016.</citation>
    <PMID>27630609</PMID>
  </results_reference>
  <results_reference>
    <citation>Martín-María N, Caballero FF, Olaya B, Rodríguez-Artalejo F, Haro JM, Miret M, Ayuso-Mateos JL. Positive Affect Is Inversely Associated with Mortality in Individuals without Depression. Front Psychol. 2016 Jul 12;7:1040. doi: 10.3389/fpsyg.2016.01040. eCollection 2016.</citation>
    <PMID>27462289</PMID>
  </results_reference>
  <results_reference>
    <citation>Raggi A, Corso B, Minicuci N, Quintas R, Sattin D, De Torres L, Chatterji S, Frisoni GB, Haro JM, Koskinen S, Martinuzzi A, Miret M, Tobiasz-Adamczyk B, Leonardi M. Determinants of Quality of Life in Ageing Populations: Results from a Cross-Sectional Study in Finland, Poland and Spain. PLoS One. 2016 Jul 19;11(7):e0159293. doi: 10.1371/journal.pone.0159293. eCollection 2016.</citation>
    <PMID>27434374</PMID>
  </results_reference>
  <results_reference>
    <citation>Tyrovolas S, Koyanagi A, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):312-21. doi: 10.1002/jcsm.12076. Epub 2015 Oct 7.</citation>
    <PMID>27239412</PMID>
  </results_reference>
  <results_reference>
    <citation>Lara E, Koyanagi A, Olaya B, Lobo A, Miret M, Tyrovolas S, Ayuso-Mateos JL, Haro JM. Mild cognitive impairment in a Spanish representative sample: prevalence and associated factors. Int J Geriatr Psychiatry. 2016 Aug;31(8):858-67. doi: 10.1002/gps.4398. Epub 2016 Feb 28.</citation>
    <PMID>26923809</PMID>
  </results_reference>
  <results_reference>
    <citation>Olaya B, Moneta MV, Koyanagi A, Lara E, Miret M, Ayuso-Mateos JL, Chatterji S, Leonardi M, Koskinen S, Tobiasz-Adamczyk B, Lobo A, Haro JM. The joint association of depression and cognitive function with severe disability among community-dwelling older adults in Finland, Poland and Spain. Exp Gerontol. 2016 Apr;76:39-45. doi: 10.1016/j.exger.2016.01.010. Epub 2016 Jan 22.</citation>
    <PMID>26805608</PMID>
  </results_reference>
  <results_reference>
    <citation>Rico-Uribe LA, Caballero FF, Olaya B, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM, Chatterji S, Ayuso-Mateos JL, Miret M. Loneliness, Social Networks, and Health: A Cross-Sectional Study in Three Countries. PLoS One. 2016 Jan 13;11(1):e0145264. doi: 10.1371/journal.pone.0145264. eCollection 2016.</citation>
    <PMID>26761205</PMID>
  </results_reference>
  <results_reference>
    <citation>Tyrovolas S, Koyanagi A, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM. The role of muscle mass and body fat on disability among older adults: A cross-national analysis. Exp Gerontol. 2015 Sep;69:27-35. doi: 10.1016/j.exger.2015.06.002. Epub 2015 Jun 3.</citation>
    <PMID>26048566</PMID>
  </results_reference>
  <results_reference>
    <citation>Koyanagi A, Stickley A, Garin N, Miret M, Ayuso-Mateos JL, Leonardi M, Koskinen S, Galas A, Haro JM. The association between obesity and back pain in nine countries: a cross-sectional study. BMC Public Health. 2015 Feb 11;15:123. doi: 10.1186/s12889-015-1362-9.</citation>
    <PMID>25886589</PMID>
  </results_reference>
  <results_reference>
    <citation>Tyrovolas S, Koyanagi A, Garin N, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM. Diabetes mellitus and its association with central obesity and disability among older adults: a global perspective. Exp Gerontol. 2015 Apr;64:70-7. doi: 10.1016/j.exger.2015.02.010. Epub 2015 Feb 16.</citation>
    <PMID>25688991</PMID>
  </results_reference>
  <results_reference>
    <citation>Tyrovolas S, Koyanagi A, Garin N, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM. Determinants of the components of arterial pressure among older adults--the role of anthropometric and clinical factors: a multi-continent study. Atherosclerosis. 2015 Feb;238(2):240-9. doi: 10.1016/j.atherosclerosis.2014.11.029. Epub 2014 Dec 9.</citation>
    <PMID>25528433</PMID>
  </results_reference>
  <results_reference>
    <citation>Miret M, Caballero FF, Chatterji S, Olaya B, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM, Ayuso-Mateos JL. Health and happiness: cross-sectional household surveys in Finland, Poland and Spain. Bull World Health Organ. 2014 Oct 1;92(10):716-25. doi: 10.2471/BLT.13.129254. Epub 2014 Aug 13.</citation>
    <PMID>25378725</PMID>
  </results_reference>
  <results_reference>
    <citation>Garin N, Olaya B, Moneta MV, Miret M, Lobo A, Ayuso-Mateos JL, Haro JM. Impact of multimorbidity on disability and quality of life in the Spanish older population. PLoS One. 2014 Nov 6;9(11):e111498. doi: 10.1371/journal.pone.0111498. eCollection 2014.</citation>
    <PMID>25375890</PMID>
  </results_reference>
  <results_reference>
    <citation>Garin N, Olaya B, Miret M, Ayuso-Mateos JL, Power M, Bucciarelli P, Haro JM. Built environment and elderly population health: a comprehensive literature review. Clin Pract Epidemiol Ment Health. 2014 Oct 21;10:103-15. doi: 10.2174/1745017901410010103. eCollection 2014.</citation>
    <PMID>25356084</PMID>
  </results_reference>
  <results_reference>
    <citation>Lara E, Olaya B, Garin N, Ayuso-Mateos JL, Miret M, Moneta V, Haro JM. Is cognitive impairment associated with suicidality? A population-based study. Eur Neuropsychopharmacol. 2015 Feb;25(2):203-13. doi: 10.1016/j.euroneuro.2014.08.010. Epub 2014 Aug 21.</citation>
    <PMID>25190638</PMID>
  </results_reference>
  <results_reference>
    <citation>Garin N, Olaya B, Lara E, Moneta MV, Miret M, Ayuso-Mateos JL, Haro JM. Visual impairment and multimorbidity in a representative sample of the Spanish population. BMC Public Health. 2014 Aug 8;14:815. doi: 10.1186/1471-2458-14-815.</citation>
    <PMID>25103270</PMID>
  </results_reference>
  <results_reference>
    <citation>Miret M, Caballero FF, Huerta-Ramírez R, Moneta MV, Olaya B, Chatterji S, Haro JM, Ayuso-Mateos JL. Factors associated with suicidal ideation and attempts in Spain for different age groups. Prevalence before and after the onset of the economic crisis. J Affect Disord. 2014 Jul;163:1-9. doi: 10.1016/j.jad.2014.03.045. Epub 2014 Apr 1.</citation>
    <PMID>24836081</PMID>
  </results_reference>
  <results_reference>
    <citation>Quintas R, Raggi A, Bucciarelli P, Franco MG, Andreotti A, Caballero FF, Olaya B, Chatterji S, Galas A, Meriläinen-Porras S, Frisoni G, Russo E, Minicuci N, Power M, Leonardi M. The COURAGE Built Environment Outdoor Checklist: an objective built environment instrument to investigate the impact of the environment on health and disability. Clin Psychol Psychother. 2014 May-Jun;21(3):204-14. doi: 10.1002/cpp.1858. Epub 2013 Jul 29.</citation>
    <PMID>23897864</PMID>
  </results_reference>
  <results_reference>
    <citation>Leonardi M, Chatterji S, Koskinen S, Ayuso-Mateos JL, Haro JM, Frisoni G, Frattura L, Martinuzzi A, Tobiasz-Adamczyk B, Gmurek M, Serrano R, Finocchiaro C; COURAGE in Europe Project's Consortium. Determinants of health and disability in ageing population: the COURAGE in Europe Project (collaborative research on ageing in Europe). Clin Psychol Psychother. 2014 May-Jun;21(3):193-8. doi: 10.1002/cpp.1856. Epub 2013 Jul 24. Review.</citation>
    <PMID>23881690</PMID>
  </results_reference>
  <results_reference>
    <citation>Perales J, Martin S, Ayuso-Mateos JL, Chatterji S, Garin N, Koskinen S, Leonardi M, Miret M, Moneta V, Olaya B, Tobiasz-Adamczyk B, Haro JM. Factors associated with active aging in Finland, Poland, and Spain. Int Psychogeriatr. 2014 Aug;26(8):1363-75. doi: 10.1017/S1041610214000520. Epub 2014 Apr 15.</citation>
    <PMID>24735743</PMID>
  </results_reference>
  <results_reference>
    <citation>Garin N, Olaya B, Perales J, Moneta MV, Miret M, Ayuso-Mateos JL, Haro JM. Multimorbidity patterns in a national representative sample of the Spanish adult population. PLoS One. 2014 Jan 20;9(1):e84794. doi: 10.1371/journal.pone.0084794. eCollection 2014. Erratum in: PLoS One. 2015;10(4):e0123037.</citation>
    <PMID>24465433</PMID>
  </results_reference>
  <results_reference>
    <citation>Caballero FF, Miret M, Power M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Olaya B, Haro JM, Ayuso-Mateos JL. Validation of an instrument to evaluate quality of life in the aging population: WHOQOL-AGE. Health Qual Life Outcomes. 2013 Oct 23;11:177. doi: 10.1186/1477-7525-11-177.</citation>
    <PMID>24152691</PMID>
  </results_reference>
  <results_reference>
    <citation>Zawisza K, Galas A, Tobiasz-Adamczyk B, Chatterji S, Haro JM, Miret M, Koskinen S, Power M, Leonardi M. The validity of the instrument to evaluate social network in the ageing population: the Collaborative Research on Ageing in Europe Social Network Index. Clin Psychol Psychother. 2014 May-Jun;21(3):227-41. doi: 10.1002/cpp.1860. Epub 2013 Aug 12.</citation>
    <PMID>23939715</PMID>
  </results_reference>
  <results_reference>
    <citation>Raggi A, Quintas R, Bucciarelli P, Franco MG, Andreotti A, Miret M, Zawisza K, Olaya B, Chatterji S, Sainio P, Frisoni GB, Martinuzzi A, Minicuci N, Power M, Leonardi M. Validation of the COURAGE Built Environment Self-Reported Questionnaire. Clin Psychol Psychother. 2014 May-Jun;21(3):215-26. doi: 10.1002/cpp.1859. Epub 2013 Jul 16.</citation>
    <PMID>23861306</PMID>
  </results_reference>
  <results_reference>
    <citation>Raggi A, Quintas R, Russo E, Martinuzzi A, Costardi D, Frisoni GB, Franco MG, Andreotti A, Ojala M, Peña S, Perales J, Chatterji S, Miret M, Tobiasz-Adamczyk B, Koskinen S, Frattura L, Leonardi M. Mapping SAGE questionnaire to the International Classification of Functioning, Disability and Health (ICF). Clin Psychol Psychother. 2014 May-Jun;21(3):199-203. doi: 10.1002/cpp.1857. Epub 2013 Jul 17.</citation>
    <PMID>23861299</PMID>
  </results_reference>
  <results_reference>
    <citation>Ayuso-Mateos JL, Miret M, Caballero FF, Olaya B, Haro JM, Kowal P, Chatterji S. Multi-country evaluation of affective experience: validation of an abbreviated version of the day reconstruction method in seven countries. PLoS One. 2013 Apr 23;8(4):e61534. doi: 10.1371/journal.pone.0061534. Print 2013.</citation>
    <PMID>23626697</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2017</study_first_submitted>
  <study_first_submitted_qc>November 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Health Status</keyword>
  <keyword>Well-being</keyword>
  <keyword>Mental Health</keyword>
  <keyword>Risk Factors</keyword>
  <keyword>Aging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>A sharing plan description has to be still agreed between the different Principal Investigators</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

